Lv31
298 积分 2023-02-09 加入
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis
4小时前
已完结
Targeting IL-6 trans-signalling: past, present and future prospects
2天前
已完结
Pharmacology and pharmacokinetics of antibody-drug conjugates, where do we stand?
1个月前
已完结
CAR T cells in autoimmune disease: On the road to remission
1个月前
已完结
The race to reset autoimmune diseases
1个月前
已完结
Defining immune reset: achieving sustained remission in autoimmune diseases
1个月前
已完结
Resetting tolerance in autoimmune disease
1个月前
已完结
Defining immune reset: achieving sustained remission in autoimmune diseases
1个月前
已完结
Allogeneic CD19-targeted CAR-T therapy in refractory systemic lupus erythematosus achieved durable remission
1个月前
已完结
CAR-T therapy in solid tumors
1个月前
已完结
皖公网安备34019202002308
